Erez Chimovits

Mr. Chimovits is a Managing Director at Orbimed. Mr. Chimovits has 14 years of operational experience, including 10 years of senior managerial experience in public companies. Prior to joining OrbiMed Mr. Chimovits was the CEO of NasVax (TASE:NSVX). NasVax acquired Protea and struck agreements with GlaxoSmithKline and Novartis. Previously, Mr. Chimovits spent more than seven years with Compugen (Nasdaq:CGEN), as President, Compugen USA Inc. and Executive VP, Commercial Operations. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions with companies such as J&J, Novartis, Teva, Abbott, Medarex and others. Mr. Chimovits earned his MBA, M.Sc. in microbiology and his B.Sc. from Tel Aviv University.